Relevance of small GTPase Rac1 pathway in drug and radio-resistance mechanisms: Opportunities in cancer therapeutics von Cardama, G.A., Alonso, D.F., Gonzalez, N., Maggio, J., Gomez, D.E., Rolfo, C., Menna, P.L

Volltext

Pharmacological inhibition of Rac1-PAK1 axis restores tamoxifen sensitivity in human resistant breast cancer cells von Gonzalez, N., Cardama, G.A., Comin, M.J., Segatori, V.I., Pifano, M., Alonso, D.F., Gomez, D.E., Menna, P.L

Volltext

Active immunotherapy with 1E10 anti-idiotype vaccine in patients with small cell lung cancer: Report of a phase I trial von Neninger, Elia, Diaz, R.M., de la Torre, A., Rives, Rolando, Diaz, Alain, Saurez, G., Gabri, M.R., Alonso, D.F., Wilkinson, B., Alfonso, A.M., Combet, T., Perez, R., Vázquez, A.M.

Volltext

1E10 anti-idiotype vaccine in non-small cell lung cancer: Experience in stage IIIb/IV patients von Alfonso, S., Díaz, R.M., de la Torre, A., Santiesteban, E., Aguirre, F., Pérez, K., Rodríguez, J.L., Barroso, M.C., Hernández, A.M., Toledo, D., Gabri, M.R., Alonso, D.F., Viada, Carmen, Gómez, R.E., Pestana, E., Suarez, Eduardo, Vázquez, A.M., Perez, R., Macías, A.

Volltext

Anti-proliferative effects of a blueberry extract on a panel of tumor cell lines of different origin von Lamdan, H, Garcia-Lazaro, R S, Lorenzo, N, Caligiuri, L G, Alonso, D F, Farina, H G

Volltext

361 POSTER N-glycolyl sialic acids as a cancer vaccine target: developing of a mouse B16 melanoma model by transient or stable expression von Gabri, M.R, Otero, L.L, Segatori, V.I, Gomez, D.E, Alonso, D.F

Volltext

Combined therapeutic effect of a monoclonal anti-idiotype tumor vaccine against NeuGc-containing gangliosides with chemotherapy in a breast carcinoma model von Fuentes, D., Avellanet, J., Garcia, A., Iglesias, N., Gabri, M. R., Alonso, D. F., Vazquez, A. M., Perez, R., Montero, E.

Volltext

Gas/Liquid Flow in Laboratory-Scale Venturis von Fernandez Alonso, D., Azzopardi, B.J., Hills, J.H.

Volltext

Impairment of fibrinolysis during the growth of two murine mammary adenocarcinomas von Alonso, D.F., Farías, E.F., Bal de Kier Joffé, E.

Volltext

Combination of Feature Extraction Methods for SVM Pedestrian Detection von Alonso, I.P., Llorca, D.F., Sotelo, M.A., Bergasa, L.M., Pedro Revenga de Toro, Nuevo, J., Ocana, M., Garrido, M.A.G.

Volltext

An electrochemical route to holey graphene nanosheets for charge storage applications von Carrasco, D.F., Paredes, J.I., Villar-Rodil, S., Suárez-García, F., Martínez-Alonso, A., Tascón, J.M.D.

Volltext

Rare and Common Variants Conferring Risk of Tooth Agenesis von Jonsson, L., Magnusson, T.E., Thordarson, A., Jonsson, T., Geller, F., Feenstra, B., Melbye, M., Nohr, E.A., Vucic, S., Dhamo, B., Rivadeneira, F., Ongkosuwito, E.M., Wolvius, E.B., Leslie, E.J., Marazita, M.L., Howe, B.J., Moreno Uribe, L.M., Alonso, I., Santos, M., Pinho, T., Jonsson, R., Audolfsson, G., Gudmundsson, L., Nawaz, M.S., Olafsson, S., Gustafsson, O., Ingason, A., Unnsteinsdottir, U., Bjornsdottir, G., Walters, G.B., Zervas, M., Oddsson, A., Gudbjartsson, D.F., Steinberg, S., Stefansson, H., Stefansson, K.

Volltext

666P Pembrolizumab (pembro) monotherapy as first-line therapy in advanced clear cell renal cell carcinoma (ccRCC): Results after a minimum of 41 months of follow-up from KEYNOTE-42... von McDermott, D.F., Lee, J-L., Bjarnason, G.A., Larkin, J., Gafanov, R., Kochenderfer, M.D., Jensen, N.V., Donskov, F., Malik, J., Poprach, A., Tykodi, S.S., Alonso-Gordoa, T., Cho, D.C., Geertsen, P.F., Climent Duran, M.A., Di Simone, C., Liu, H., Burgents, J., Rodriguez-Lopez, K., Atkins, M.B.

Volltext

Influence of parity on the oxidative balance in pregnant and postpartum mares von Rohof, J.E., Alonso, M.A., Souza, D.F., Lemes, K.M., Nichi, M., Fernandes, C.B.

Volltext

KEYNOTE-427 cohort A: Pembrolizumab monotherapy as first-line therapy in advanced clear cell renal cell carcinoma (ccRCC) von Donskov, F., McDermott, D.F., Lee, J.L., Szczylik, C., Malik, J., Alekseev, B.Y., Larkin, J.M.G., Matveev, V.B., Airatovich Gafanov, R., Tomczak, P., Tykodi, S.S., Geertsen, P.F., Wiechno, P., Shin, S.J., Pouliot, F., Alonso Gordoa, T., Kloss Silverman, R., Perini, R.F., Schloss, C., Atkins, M.B.

Volltext

MRPL53, a New Candidate Gene for Orofacial Clefting, Identified Using an eQTL Approach von Masotti, C., Brito, L.A., Nica, A.C., Ludwig, K.U., Nunes, K., Savastano, C.P., Malcher, C., Ferreira, S.G., Kobayashi, G.S., Bueno, D.F., Alonso, N., Franco, D., Rojas-Martinez, A., dos Santos, S.E., Galante, P.A., Meyer, D., Hünemeier, T., Mangold, E., Dermitzakis, E.T., Passos-Bueno, M.R.

Volltext

949P - First-line pembrolizumab (pembro) monotherapy in advanced clear cell renal cell carcinoma (ccRCC): Updated follow-up for KEYNOTE-427 cohort A von Larkin, J.M.G., Tykodi, S.S., Donskov, F., Lee, J.-L., Szczylik, C., Malik, J., Alekseev, B.Y., Matveev, V.B., Gafanov, R.A., Tomczak, P., Geertsen, P.F., Wiechno, P.J., Shin, S.J., Pouliot, F., Alonso Gordoa, T., Kloss Silverman, R., Perini, R.F., Schloss, C., McDermott, D.F., Atkins, M.B.

Volltext

First-line pembrolizumab (pembro) monotherapy in advanced clear cell renal cell carcinoma (ccRCC): Updated follow-up for KEYNOTE-427 cohort A von Larkin, J.M.G., Tykodi, S.S., Donskov, F., Lee, J.-L., Szczylik, C., Malik, J., Alekseev, B.Y., Matveev, V.B., Gafanov, R.A., Tomczak, P., Geertsen, P.F., Wiechno, P.J., Shin, S.J., Pouliot, F., Alonso Gordoa, T., Kloss Silverman, R., Perini, R.F., Schloss, C., McDermott, D.F., Atkins, M.B.

Volltext

Targeting the NAFLD metabolome and the shaping of precision medicine for patients with NASH von Iruarrizaga-Lejarreta, M., Martínez-Arranz, I., Morrison, M.C., Varela-Rey, M., Ramos, D.F., Delacruz-Villar, L., Noureddin, M., Martínez-Chantar, M.L., Kleemann, R., Alonso, C., Lu, S.C., Mato, J.M.

Volltext

THU-516 - Targeting the NAFLD metabolome and the shaping of precision medicine for patients with NASH von Iruarrizaga-Lejarreta, M., Martínez-Arranz, I., Morrison, M.C., Varela-Rey, M., Ramos, D.F., Delacruz-Villar, L., Noureddin, M., Martínez-Chantar, M.L., Kleemann, R., Alonso, C., Lu, S.C., Mato, J.M.

Volltext